Oakworth Capital’s Merck MRK Stock Holding History

Oakworth Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.76M	Sell	37,177 -1,830	-5%	-$214K	0.23%	38
2026 Q1	$4.69M	Sell	39,007 -2,749	-7%	-$317K	0.25%	34
2025 Q4	$4.4M	Sell	41,756 -3,138	-7%	-$295K	0.24%	34
2025 Q3	$3.77M	Sell	44,894 -34	-0.1%	-$2.8K	0.22%	38
2025 Q2	$3.56M	Sell	44,928 -1,826	-4%	-$145K	0.23%	33
2025 Q1	$4.2M	Buy	46,754 +23,622	+102%	+$2.21M	0.29%	29
2024 Q4	$2.3M	Buy	23,132 +2,316	+11%	+$239K	0.16%	48
2024 Q3	$2.36M	Buy	20,816 +330	+2%	+$39.2K	0.16%	47
2024 Q2	$2.54M	Buy	20,486 +254	+1%	+$32.7K	0.19%	43
2024 Q1	$2.67M	Buy	20,232 +996	+5%	+$123K	0.2%	42
2023 Q4	$2.1M	Buy	19,236 +1,779	+10%	+$185K	0.17%	43
2023 Q3	$1.8M	Sell	17,457 -179	-1%	-$19.3K	0.16%	46
2023 Q2	$2.04M	Buy	17,636 +402	+2%	+$45.6K	0.17%	42
2023 Q1	$1.83M	Sell	17,234 -124	-0.7%	-$13.4K	0.16%	43
2022 Q4	$1.93M	Sell	17,358 -1,580	-8%	-$162K	0.18%	36
2022 Q3	$1.63M	Buy	18,938 +147	+0.8%	+$13.1K	0.18%	40
2022 Q2	$1.71M	Sell	18,791 -125	-0.7%	-$11.1K	0.17%	42
2022 Q1	$1.55M	Sell	18,916 -1,452	-7%	-$114K	0.13%	51
2021 Q4	$1.56M	Buy	20,368 +1,072	+6%	+$85.4K	0.13%	52
2021 Q3	$1.45M	Sell	19,296 -1,070	-5%	-$81.4K	0.14%	48
2021 Q2	$1.58M	Sell	20,366 -700	-3%	-$52.1K	0.16%	43
2021 Q1	$1.55M	Buy	21,066 +2,820	+15%	+$208K	0.18%	44
2020 Q4	$1.42M	Sell	18,246 -5,289	-22%	-$405K	0.18%	41
2020 Q3	$1.86M	Sell	23,535 -75	-0.3%	-$5.88K	0.3%	31
2020 Q2	$1.74M	Buy	23,610 +2,386	+11%	+$180K	0.31%	30
2020 Q1	$1.56M	Buy	21,224 +1,034	+5%	+$81.3K	0.37%	28
2019 Q4	$1.71M	Buy	20,190 +1,361	+7%	+$112K	0.3%	31
2019 Q3	$1.51M	Sell	18,829 -8,908	-32%	-$714K	0.29%	34
2019 Q2	$2.22M	Sell	27,737 -826	-3%	-$63.2K	0.42%	29
2019 Q1	$2.27M	Sell	28,563 -30	-0.1%	-$2.24K	0.46%	27
2018 Q4	$2.08M	Buy	28,593 +191	+0.7%	+$13.5K	0.47%	26
2018 Q3	$1.92M	Buy	28,402 +920	+3%	+$58.6K	0.38%	31
2018 Q2	$1.59M	Sell	27,482 -875	-3%	-$49.4K	0.33%	32
2018 Q1	$1.59M	Buy	28,357 +2,798	+11%	+$151K	0.38%	28
2017 Q4	$1.35M	Sell	25,559 -834	-3%	-$46.2K	0.32%	32
2017 Q3	$1.61M	Buy	26,393 +598	+2%	+$36.3K	0.41%	28
2017 Q2	$1.58M	Buy	25,795 +833	+3%	+$50.7K	0.43%	28
2017 Q1	$1.51M	Sell	24,962 -243	-1%	-$14.7K	0.44%	29
2016 Q4	$1.47M	Buy	25,205 +950	+4%	+$55.6K	0.48%	31
2016 Q3	$1.44M	Sell	24,255 -4,861	-17%	-$284K	0.5%	27
2016 Q2	$1.56M	Sell	29,116 -91	-0.3%	-$4.84K	0.58%	26
2016 Q1	$1.47M	Buy	29,207 +596	+2%	+$29.2K	0.59%	26
2015 Q4	$1.44M	Buy	28,611 +19,272	+206%	+$972K	0.6%	25
2015 Q3	$440K	Hold	9,339	–	–	0.23%	44
2015 Q2	$525K	Hold	9,339	–	–	0.25%	43
2015 Q1	$531K	Hold	9,339	–	–	0.25%	47
2014 Q4	$506K	Hold	9,339	–	–	0.26%	44
2014 Q3	$536K	Hold	9,339	–	–	0.31%	37
2014 Q2	$515K	Hold	9,339	–	–	0.31%	39
2014 Q1	$506K	Hold	9,339	–	–	0.33%	37
2013 Q4	$446K	Buy	+9,339	New	+$427K	0.32%	36

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Oakworth Capital's MRK Position: Q2 2026 in Review

Oakworth Capital reduced its Merck (MRK) stake by 4.7% in Q2 2026, selling an estimated $214K and leaving 37,177 shares worth $4.76M. The position accounts for 0.23% of the portfolio, ranked #38.

Oakworth Capital first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. 1,126 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Oakworth Capital held 37,177 shares of Merck worth $4.76M as of Q2 2026.
Oakworth Capital sold 1,830 Merck shares in Q2 2026, an estimated $214K.
Merck made up 0.23% of Oakworth Capital's portfolio in Q2 2026, its #38 holding.
Oakworth Capital first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
1,126 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.